All News
Normalizing Serologies Enhances Remission in SLE
Analysis of five phase III belimumab (BEL) trials reveals that normalizing serologies affords protection against severe and renal SLE flares, supporting the concept of treat-to-target to minimize risk in SLE.
Intraarticular Steroids in OA Lowers Need for Pain Meds
d
MedPage Today
Is it possible that intra-articular corticosteroid injections for osteoarthritis might affect the use of opioids?
SOCS1 Insufficiency - a Rare Inborn Error of Immunity
Lancet Rheumatology has published a population study of the rare suppressor of cytokine signalling 1 (SOCS1) insufficiency - an inborn error of immunity affecting the negative regulation of cytokine and growth factor signalling.
Read ArticleEarly Hydroxychloroquine Slows Cutaneous Lupus Progression
A prospective study of patients with limited cutaneous lupus erythematosus shows that early introduction of hydroxychloroquine may prevent progression to systemic lupus erythematosus.

Full read review of Hydryoxychloroquine -its pharmacology, MOA (eg, blocking TLR 7 & 9), Dz specific efficacy and adverse effects https://t.co/WVErW1RrCj https://t.co/eQVFIZNSRx
Dr. John Cush RheumNow ( View Tweet)

Bubble Trouble - When Bullous Lupus Bursts onto the SLE Scene
Presentation by Dr. Alana Haussmann at the Rheumatology Winter Clinical Symposia - Feb 2025
https://t.co/LRsT1TLEm4 https://t.co/bSi50pDn2O
Dr. John Cush RheumNow ( View Tweet)

Opioid Deaths are Down (2.28.2025)
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow. Opioid deaths are down, IL-33 levels are up and Weight loss is in the news again this week!
https://t.co/Lb6F64AlNJ https://t.co/7AjSXOn142
Dr. John Cush RheumNow ( View Tweet)

Loss of Good Sleep Linked to All-Cause Mortality
A US study shows that nearly two-thirds of the population had suboptimal 5-year sleep duration trajectories with a resultant 29% increase in risk of all-cause mortality.
https://t.co/GXkIDC2uSQ https://t.co/wYzpnK9BMQ
Dr. John Cush RheumNow ( View Tweet)

Recurrent Pericarditis in Lupus
A study from the Lupus Hopkins Cohort shows that systemic lupus erythematosus (SLE) patients with pericarditis are at risk for recurrence, and likely to be younger patients, with uncontrolled disease, and linkage to higher doses of oral… https://t.co/hML8NfhBy3 https://t.co/cKX5KaSg3a
Dr. John Cush RheumNow ( View Tweet)

Risk of Cancer on JAKi in RA (12 463 vs 38 345 controls). No incr risk of CA w/ exposure to JAKi (adj OR 1.04), TNFi (0.98), other bDMARDs (0.98). But JAKi was assoc w/ signif more lung CA (1.40; esp in males 2.12) & less breast CA (0.62) in women https://t.co/fr3VjPhJve https://t.co/zNehdWBbeI
Dr. John Cush RheumNow ( View Tweet)

Selective mutation of Traf1/cIAP2 (V196) interaction attenuates inflammatory responses that may contribute to rheumatoid arthritis activity. THis may lead to a new class of therapies for RA https://t.co/kYqAqGsSEA https://t.co/JWUN6iTvxa
Dr. John Cush RheumNow ( View Tweet)

I ALWAYS recommend paraffin wax baths for stiffness, RA, OA, PSS, etc.
Here are some instructions for home use https://t.co/CTI4K2kHf9 https://t.co/i0kO99vdYc
Dr. John Cush RheumNow ( View Tweet)

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Giant Cell Arteritis https://t.co/WP8JGpHc6p https://t.co/x9m870mCJ4
Dr. John Cush RheumNow ( View Tweet)

UK MRCP exam makeup:
Cardio 15%
Pharm 15%
Resp 10%
GI 10%
Neuro 10%
ID 8%
Endo 8%
RHEUM 6%
Heme 5%
Renal 5%
Derm 4%
Eye 2%
Psych 2% https://t.co/WG7X3B8a0Y https://t.co/9VF5LkLJjs
Dr. John Cush RheumNow ( View Tweet)

Cochrane review of TNF inhib. in #JIA shows TNFi efficacy, but uncertainty about LT safety, pain, function, & Dz control - esp compared to MTX. 9 studies, 678 JIApts, age 8-15 yrs (80% F), Dz duration 0.8-6.7 yrs. Withdrawls 1% v 3%; Serious AE 6% v 7% (PBO vs TNFi).… https://t.co/i35m5uzG1m https://t.co/VzJN9PmmMh
Dr. John Cush RheumNow ( View Tweet)

"Never take the advice of someone who has not had your kind of trouble"
- Sidney J. Harris https://t.co/xdB6u6OiPq
Dr. John Cush RheumNow ( View Tweet)

Ankle Fusion or Total Replacement?
In a large study of British patients needing surgical treatment for advanced arthritis in the ankle, fusion appeared to be a better option than total ankle replacement.
https://t.co/ZFbd2VinpP https://t.co/QCqMkxNLoQ
Dr. John Cush RheumNow ( View Tweet)

Schnitzler Syndrome: A Rare Autoinflammatory Disorder
A credible, quick overview
Chronic Urticaria
Monoclonal Gammopathy (
Recurrent Fever
Bone & Joint Pain
Elevated CRP &ESR https://t.co/sQ22t8Z46m https://t.co/nJOVCghoFa
Dr. John Cush RheumNow ( View Tweet)

Diagnoses via Immune ‘Fingerprints’
Science and researchers at Stanford Medicine have reported the use of Mal-ID (machine learning for immunological diagnosis) to analyze B and T cell receptors (BCRs and TCRs) sequences from human blood, showing the ability to predict health… https://t.co/nqyf4iaD10 https://t.co/wt5V6uxLYf
Dr. John Cush RheumNow ( View Tweet)

JAMA Case: A Woman With Painful Digital Ulcers - What would you order next?
- chest CT w/ myositis-specific autoAb panel
- dsDNA
- SCL-70 & Centromere Abs
- muscle biopsy https://t.co/t0WCIMtZg2 https://t.co/M1jBhnclLl
Dr. John Cush RheumNow ( View Tweet)